[Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). I. Effect on central and peripheral nervous systems (author's transl)].
Source:http://linkedlifedata.com/resource/pubmed/id/909142
